Literature DB >> 3490625

Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis.

H V New, A W Mudge.   

Abstract

Innervation of muscle by motoneurones induces the development of a characteristic, high density cluster of acetylcholine receptors (AChRs) at the neuromuscular junction. Studies in vitro show that the accumulation of AChRs at nerve-muscle contacts results from both increased insertion of new AChRs into the muscle plasma membrane beneath nerve terminals and redistribution of preexisting AChRs; these two modes of AChR accumulation may be separately controlled since factors have been identified that influence AChR redistribution but not synthesis. Although many aspects of muscle development are regulated by nerve-dependent muscle activity, junctional AChR clusters still develop when neuromuscular transmission is blocked by either curare or alpha-bungarotoxin, suggesting that their formation is mediated by nerve-derived trophic factors other than activity. A molecule immunologically related to calcitonin gene-related peptide (CGRP-I) has been found in motoneurones in a variety of mammals including man. Here we provide indirect evidence that CGRP-I may be a motoneurone-derived trophic factor that increases AChR synthesis at vertebrate neuromuscular junctions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490625     DOI: 10.1038/323809a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  89 in total

1.  Short- and long-term influences of calcitonin gene-related peptide on the synthesis of acetylcholinesterase in mammalian myotubes.

Authors:  V L da Costa; A J Lapa; R O Godinho
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Organelles in fast axonal transport. What molecules do they carry in anterograde vs retrograde directions, as observed in mammalian systems?

Authors:  A B Dahlström; A J Czernik; J Y Li
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

3.  Studies on the distribution of calcitonin gene-related peptide-like and substance P-like immunoreactivities in rat hind limb muscles.

Authors:  S Forsgren; A Bergh; E Carlsson; L E Thornell
Journal:  Histochem J       Date:  1992-06

4.  The 5'-flanking region of the mouse muscle nicotinic acetylcholine receptor beta subunit gene promotes expression in cultured muscle cells and is activated by MRF4, myogenin and myoD.

Authors:  C A Prody; J P Merlie
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

5.  Developmentally regulated expression of calcitonin gene-related peptide at mammalian neuromuscular junction.

Authors:  M Matteoli; S Balbi; C Sala; B Chini; M Cimino; M Vitadello; G Fumagalli
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

Review 6.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

7.  The relationship between innervation and arterial structure in late prenatal and early postnatal development of the rat jejunal artery.

Authors:  J R Woolgar; T M Scott
Journal:  J Anat       Date:  1989-12       Impact factor: 2.610

8.  Regulation of nicotinic acetylcholine receptor phosphorylation in rat myotubes by forskolin and cAMP.

Authors:  K Miles; D T Anthony; L L Rubin; P Greengard; R L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Regulation of intracellular cyclic AMP in skeletal muscle cells involves the efflux of cyclic nucleotide to the extracellular compartment.

Authors:  Rosely Oliveira Godinho; Valter Luiz Costa
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy.

Authors:  M I Romero; N Rangappa; M G Garry; G M Smith
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.